Accretive Health, Inc. (AH) Reports In-Line Q1 EPS, Reaffirm FY11 Guidance

May 11, 2011 7:41 AM EDT
Accretive Health, Inc. (NYSE: AH) reported Q1 adjusted EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $163.7 million versus the consensus estimate of $168.41 million.

Accretive Health, Inc. sees FY2011 EPS of $0.42-$0.45, versus the consensus of $0.45.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings